These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15764406)

  • 21. [Surface properties of cerebrospinal fluid cells following intrathecal methotrexate treatment].
    Péter A; Kádár A
    Morphol Igazsagugyi Orv Sz; 1978 Jan; 18(1):16-22. PubMed ID: 580307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
    Yuan SH; Ge WH; Huo J; Wang XH
    Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of methotrexate in systemic tissues after intrathecal administration.
    Bleyer WA; Nelson JA; Kamen BA
    J Pediatr Hematol Oncol; 1997; 19(6):530-2. PubMed ID: 9407940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of local administration of methotrexate bound to activated carbon particles (MTX-CH)].
    Ito T; Takagi T; Shimomura K; Takemura M; Toma A; Fujiyama J; Sonoyama Y; Sakakura C; Ootsuji E; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1696-8. PubMed ID: 11708012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of topical delivery of methotrexate by electroporation.
    Wong TW; Zhao YL; Sen A; Hui SW
    Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
    Wolff D; Frei E; Hofmeister N; Steiner B; Kleine HD; Junghanss C; Sievert K; Terpe H; Schrenk HH; Freund M; Hartung G
    Transplantation; 2006 Aug; 82(4):527-33. PubMed ID: 16926597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
    Cole BF; Glantz MJ; Jaeckle KA; Chamberlain MC; Mackowiak JI
    Cancer; 2003 Jun; 97(12):3053-60. PubMed ID: 12784341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.
    Doddoli C; Ghez O; Barlési F; D'journo B; Robitail S; Thomas P; Clerc T
    Int J Pharm; 2005 Jun; 297(1-2):180-9. PubMed ID: 15869851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
    Todeschini G; Tecchio C; Pasini F; Benedetti F; Cantini M; Crippa C; Draisci M; Pizzolo G
    Cancer; 2005 Aug; 104(3):555-60. PubMed ID: 15959910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance.
    Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Muià C; Caputi AP; Salvemini D
    Arthritis Rheum; 2005 Dec; 52(12):3755-60. PubMed ID: 16320326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
    Park J; Franco RS; Augsburger JJ; Banerjee RK
    Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Kellie SJ; Chaku J; Lockwood LR; O'Regan P; Waters KD; Wong CK;
    Eur J Cancer; 2005 Jul; 41(11):1588-96. PubMed ID: 16026694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA; Martínez Colmenero C; Peláez Pleguezuelos I; Leiva Gea I; López García AB; de la Cruz Moreno J
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.